Transdermal buprenorphine patch: Potential for role in management of opioid dependence.


Journal

Asian journal of psychiatry
ISSN: 1876-2026
Titre abrégé: Asian J Psychiatr
Pays: Netherlands
ID NLM: 101517820

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 18 11 2018
revised: 28 01 2019
accepted: 07 02 2019
pubmed: 18 2 2019
medline: 30 7 2019
entrez: 18 2 2019
Statut: ppublish

Résumé

Despite proven clinical utility, use of sublinugual buprenorphine is fraught with issues of potential diversion among patients with opioid dependence. Transdermal buprenorphine patches provide an alternative delivery model that can be utilized to reduce such diversion. This narrative review discusses the transdermal buprenorphine formulations, and its pharmacology, drug interaction and tolerability profile. The studies utilizing buprenorphine transdermal patches in the treatment of opioid dependence are examined, while the potential of using such patches for maintenance treatment of opioid dependence is examined.

Identifiants

pubmed: 30772733
pii: S1876-2018(18)31076-1
doi: 10.1016/j.ajp.2019.02.002
pii:
doi:

Substances chimiques

Narcotic Antagonists 0
Buprenorphine 40D3SCR4GZ

Types de publication

Journal Article Review

Langues

eng

Pagination

88-91

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Anju Dhawan (A)

Professor, Department of Psychiatry and National Drug Dependence Treatment Center, All India Institute of Medical Sciences, New Delhi.

Tamonud Modak (T)

Senior Resident, Department of Psychiatry and National Drug Dependence Treatment Center, All India Institute of Medical Sciences, New Delhi. Electronic address: tamonud4@gmail.com.

Siddharth Sarkar (S)

Assistant Professor, Department of Psychiatry and National Drug Dependence Treatment Center, All India Institute of Medical Sciences, New Delhi.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH